Description

Hepatocellular Carcinoma (HCC): The Silent Threat in Liver Disease Hepatocellular Carcinoma (HCC) is the most common primary liver cancer, often developing in patients with cirrhosis and chronic liver disease. It is a leading cause of cancer-related deaths, especially in India, where Hepatitis B, Hepatitis C, MAFLD, and alcohol-related liver disease are major risk factors. Early detection is critical, as survival depends on timely intervention. Who is at Risk? 🔹 Cirrhosis (Any Cause) – The strongest predictor of HCC. 🔹 Hepatitis B & C Infection – Even without cirrhosis, increases cancer risk. 🔹 Metabolic-Associated Fatty Liver Disease (MAFLD) – A rising cause of liver cancer in India. 🔹 Alcohol & Aflatoxin Exposure – Common in high-risk regions. How Does HCC Present? ⚠️ Early Stages: Often silent, detected only on routine liver screening. ⚠️ Advanced: Weight loss, persistent pain in the upper abdomen, jaundice, and swelling. ⚠️ Severe: Tumor rupture, internal bleeding, liver failure. HCC Diagnosis & Treatment: ✔️ Regular Screening: 6-monthly ultrasound & AFP testing for high-risk patients. ✔️ Triphasic CT/MRI Scan: Gold standard for HCC detection. ✔️ Curative Options (Early HCC): Liver resection or liver transplant. ✔️ Advanced HCC Treatment: 🔹 Transarterial Chemoembolization (TACE) – Shrinks tumors in unresectable cases. 🔹 Targeted Therapy (Sorafenib, Lenvatinib) & Immunotherapy – For metastatic cases. Why Choose Dr. Chetan Kalal for HCC Management? 🏥 India’s Leading Hepatologist & Liver Cancer Specialist 🔬 Expert in Advanced HCC Therapies & Liver Transplantation ⚕️ High Success Rates in Managing Complex Liver Cancer Cases 💡 HCC is aggressive but treatable if caught early—Don't Delay Screening & Expert Care! #DrChetanKalal #BestHepatologistIndia #BestHepatologistInMumbai #LiverCancer #HCC #Cirrhosis #Hepatitis #HepatologyExpert #LiverTransplant